Characterization of the Regional Intestinal Kinetics of Drug Efflux in Rat and Human Intestine and in Caco-2 Cells

AbstractPurpose. The aim of the present study was to investigate the transport kinetics of intestinal secretory processes in the jejunum, ileum and colon of rats and humans and in Caco-2 cells, in vitro. Methods. Etoposide, vinblastine sulphate and verapamil hydrochloride were chosen as model substrates since they have been reported to undergo efflux in various other tissues. The concentration dependence, inhibition, directionality, temperature dependence, proton/sodium dependence, and ATP dependence of efflux were studied using side-by-side diffusion chambers and brush border membrane vesicles (BBMVs). Intestinal tissue from rats and humans and Caco-2 cells (passage no. 26) were used. Directional steady state effective permeabilities were calculated from drug appearance in the apical (AP) or basolateral (BL) chambers. Kinetic studies were carried out by investigating substrate efflux at concentrations ranging from 0.2 μM to 1000 μM. Since substrate efflux may be a result of more than one transporter, the hybrid efflux Km (Michaelis-constant), Pc (carrier-mediated permeability), and Pm (passive permeability) were determined as a function of intestinal region. Inhibitor studies were performed using quinidine (0.2 mM), a mixed inhibitor of P-glycoprotein (Pgp) and Multidrug Resistance-Associated Protein (MRP), and Leukotriene C4(100 nM), an inhibitor of MRP and the canalicular multispecific organic anion transporter (cMOAT). Temperature dependent efflux was determined by investigating the BL to AP transport at temperatures ranging from 3°C to 37°C. Energies of activation (Ea) were determined from an Arrhenius analysis. Sodium, proton, and ATP dependence were determined using BBMVs. Immunoquantitation of Pgp, MRP and Lung Resistance Protein (LRP) in Caco-2 cells were carried out using Western blot analysis. Results. Active efflux of all substrates was observed in all regions of rat and human intestine and in Caco-2 cells. Directionality was observed with BL to AP transport exceeding AP to BL transport. The BL to AP/AP to BL permeability ratio, the efflux ratio, ranged from 1.4 to 19.8. Heal efflux was significantly higher (p < 0.001) than in other regions. Kinetic studies revealed that hybrid efflux Km values ranged from 4 to 350 μM. In some cases, efflux was not saturable due to the solubility limits of the compounds utilized in this study. In presence of inhibitors, efflux ratios approached 1. BL to AP transport was temperature dependent in rat ileum for all substrates. Ea of intestinal efflux was found to be 11.6, 8.3, and 15.8 kcal/mole for etoposide, vinblastine and verapamil, respectively, suggesting an active, energy-dependent efflux mechanism. Substrate efflux was not sodium or proton dependent but was dependent on ATP. Using Western blot analysis the presence of Pgp, MRP, and LRP was demonstrated in Caco-2 cells and the amount of each transport protein varied as a function of passage number. Conclusions. Using multiple putative efflux substrates, the current results demonstrate that intestinal efflux was regionally dependent, mediated by multiple efflux transporters, the Km’s were in the micro-molar range, and involved an energy dependent mechanism(s).

[1]  Z. Gatmaitan,et al.  Structure and function of P-glycoprotein in normal liver and small intestine. , 1993, Advances in pharmacology.

[2]  R. Conradi,et al.  Evidence for a polarized efflux system for peptides in the apical membrane of Caco-2 cells. , 1993, Biochemical and biophysical research communications.

[3]  G. Giaccone,et al.  Broad distribution of the multidrug resistance-related vault lung resistance protein in normal human tissues and tumors. , 1996, The American journal of pathology.

[4]  A. Schinkel,et al.  P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. , 1996, The Journal of clinical investigation.

[5]  K. Tew,et al.  ATP-dependent uptake of natural product cytotoxic drugs by membrane vesicles establishes MRP as a broad specificity transporter. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[6]  L. Reinlib,et al.  Freeze-thaw and high-voltage discharge allow macromolecule uptake into ileal brush-border vesicles. , 1987, The American journal of physiology.

[7]  D. Roden,et al.  The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. , 1998, The Journal of clinical investigation.

[8]  D. Keppler,et al.  The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. , 1994, The Journal of biological chemistry.

[9]  L. Benet,et al.  Tacrolimus oral bioavailability doubles with coadministration of ketoconazole , 1997, Clinical pharmacology and therapeutics.

[10]  I. Hidalgo,et al.  Transport of a large neutral amino acid (phenylalanine) in a human intestinal epithelial cell line: Caco-2. , 1990, Biochimica et biophysica acta.

[11]  J. Alsenz,et al.  Active Apical Secretory Efflux of the HIV Protease Inhibitors Saquinavir and Ritonavir in Caco-2 Cell Monolayers , 1998, Pharmaceutical Research.

[12]  P. Augustijns,et al.  Evidence for a polarized efflux system in CACO-2 cells capable of modulating cyclosporin A transport. , 1993, Biochemical and biophysical research communications.

[13]  M. Cavet,et al.  Transport and epithelial secretion of the cardiac glycoside, digoxin, by human intestinal epithelial (Caco‐2) cells , 1996, British journal of pharmacology.

[14]  H. Saitoh,et al.  Possible Involvement of Multiple P-Glycoprotein-Mediated Efflux Systems in the Transport of Verapamil and Other Organic Cations Across Rat Intestine , 1995, Pharmaceutical Research.

[15]  C. Meijer,et al.  Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies. , 1994, Cancer research.

[16]  M. Müller,et al.  Secretion of Organic Anions by Hepatocytes: Involvement of Homologues of the Multidrug Resistance Protein , 1996, Seminars in liver disease.

[17]  Z. Gatmaitan,et al.  The function of Gp170, the multidrug-resistance gene product, in the brush border of rat intestinal mucosa. , 1992, Gastroenterology.

[18]  T. Márián,et al.  Intracellular pH does not affect drug extrusion by P-glycoprotein. , 1996, Journal of photochemistry and photobiology. B, Biology.

[19]  T. Tsuruo,et al.  Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells. Kinetics of vinblastine secretion and interaction with modulators. , 1993, The Journal of biological chemistry.

[20]  V. H. Lee,et al.  Age-dependent Expression of P-Glycoprotein gp17O in Caco-2 Cell Monolayers , 1996, Pharmaceutical Research.

[21]  S. Su,et al.  Inhibition of the intestinal digoxin absorption and exsorption by quinidine. , 1996, Drug Metabolism And Disposition.

[22]  Leslie Z. Benet,et al.  Intestinal drug metabolism and antitransport processes : A potential paradigm shift in oral drug delivery , 1996 .

[23]  P. Artursson,et al.  Transport of celiprolol across human intestinal epithelial (Caco‐2) cells: mediation of secretion by multiple transporters including P‐glycoprotein , 1993, British journal of pharmacology.

[24]  P. Sinko,et al.  Oral absorption of anti-acquired immune deficiency syndrome nucleoside analogues. 2. Carrier-mediated intestinal transport of stavudine in rat and rabbit preparations. , 1996, Journal of pharmaceutical sciences.

[25]  Y. Sugiyama,et al.  Molecular cloning of canalicular multispecific organic anion transporter defective in EHBR. , 1997, The American journal of physiology.

[26]  J. H. Beijnen,et al.  Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs , 1994, Cell.

[27]  S. Aaronson,et al.  Expression complementary DNA library transfer establishes mrp as a multidrug resistance gene. , 1994, Cancer research.

[28]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[29]  D. Schadendorf,et al.  Membrane transport proteins associated with drug resistance expressed in human melanoma. , 1995, The American journal of pathology.

[30]  Y. Sai,et al.  Active Secretion of Drugs from the Small Intestinal Epithelium in Rats by P‐Glycoprotein Functioning as an Absorption Barrier , 1996, The Journal of pharmacy and pharmacology.

[31]  D. Scherman,et al.  Polarized transport of docetaxel and vinblastine mediated by P-glycoprotein in human intestinal epithelial cell monolayers. , 1994, Biochemical pharmacology.

[32]  G. M. Wilson,et al.  Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. , 1994, Cancer research.

[33]  S. Akiyama,et al.  Lung resistance protein (LRP) expression in human normal tissues in comparison with that of MDR1 and MRP. , 1997, Cancer letters.

[34]  H. Saitoh,et al.  The secretory intestinal transport of some beta-lactam antibiotics and anionic compounds: a mechanism contributing to poor oral absorption. , 1996, The Journal of pharmacology and experimental therapeutics.

[35]  D. Keppler,et al.  The canalicular multidrug resistance protein, cMRP/MRP2, a novel conjugate export pump expressed in the apical membrane of hepatocytes. , 1997, Advances in enzyme regulation.

[36]  B. Hirst,et al.  Intestinal secretion of drugs. The role of P-glycoprotein and related drug efflux systems in limiting oral drug absorption , 1997 .

[37]  S. Cole,et al.  Multidrug resistance protein (MRP)-mediated transport of leukotriene C4 and chemotherapeutic agents in membrane vesicles. Demonstration of glutathione-dependent vincristine transport. , 1996, The Journal of biological chemistry.